Skip to content

Advertisement

  • Research article
  • Open Access

Identification of a subunit of NADH-dehydrogenase as a p49/STRAP-binding protein

BMC Cell Biology20089:8

https://doi.org/10.1186/1471-2121-9-8

©  Zhang et al; licensee BioMed Central Ltd. 2008

  • Received: 01 August 2007
  • Accepted: 29 January 2008
  • Published:

Abstract

Background

The p49/STRAP (or SRFBP1) protein was recently identified in our laboratory as a cofactor of serum response factor that contributes to the regulation of SRF target genes in the heart.

Results

In the present study, we report that NDUFAB1, a nuclear encoded subunit of NADH dehydrogenase, represented the majority of the cDNA clones that interacted with p49/STRAP in multiple screenings using the yeast two-hybrid system. The p49/STRAP and NDUFAB1 proteins interacted and co-localized with each other in the cell. The p49/STRAP protein contains four classic nuclear localization sequence motifs, and it was observed to be present predominantly in the nucleus. Overexpression of p49/STRAP altered the intracellular level of NAD, and reduced the NAD/NADH ratio. Overexpression of p49/STRAP also induced the deacetylation of serum response factor.

Conclusion

These data suggest that p49/STRAP plays a role in the regulation of intracellular processes such as cardiac cellular metabolism, gene expression, and possibly aging.

Keywords

  • NADH Dehydrogenase
  • H9C2 Cell
  • Recombinant Adenovirus
  • Serum Response Factor
  • Neonatal Cardiac Myocytes

Background

A novel protein, p49/STRAP, was recently identified in our laboratory [1]. The initial observations indicated that p49/STRAP is a cofactor of serum response factor (SRF) contributing to the regulation of SRF target genes in the heart. This gene was later named by The Human Genome Organization (HUGO) as SRFBP1 based on our initial finding that p49/STRAP binds to SRF. The p49/STRAP mRNA and protein are expressed in multiple tissues, including heart, brain, liver, skeletal muscle and kidney. An increase of p49/STRAP expression has been observed in the myocardium of human and mouse with advancing age, and also in transgenic mice suffering from cardiomyopathy [1, 2].

Our previous studies suggested that the expression of a number of cardiac genes are regulated by a protein complex containing SRF and it's multiple binding proteins, including p49/STRAP and Zipzap/p200 [1–3]. We had noticed that the protein complexes obtained by immunoprecipitation assays with either p49/STRAP or SRF antibody contained more components than we had anticipated, suggesting that additional proteins may be present in the complex [1–3]. The p49/STRAP protein interacts directly with the SRF transcriptional activation domain. Therefore, it is possible that a protein complex formed around this domain or those proteins that bind to p49/STRAP may have a significant effect on SRF activation. In an attempt to determine the identity of these putative proteins, we used p49/STRAP protein fragments as bait in the yeast two-hybrid system. We found that NDUFAB1, a subunit of NADH dehydrogenase (a nuclear encoded subunit of mitochondrial Complex I), represented the majority of cDNA clones interacting with p49/STRAP in the multiple screenings. Overexpression of p49 changed the intracellular NAD/NADH ratio and reduced the amount of acetylated-SRF protein. Therefore, p49 may play a role in the process of protein acetylation and deacetylation, thereby modulating transcriptional regulation.

Methods

Yeast Two-hybrid Screening and Bioinformatic Analysis

Yeast two-hybrid screening was performed as previously described [1]. Briefly, one "bait" construct containing the N-terminus (residues 1–256) and another one containing the C-terminus (residues 250–427) of the p49/STRAP protein were used to screen cDNA libraries generated from a human heart and Hela cells (Clontech). A total of three separate screenings was performed. Positive target cDNA clones were subjected to a series of analyses according to the manufacturer's instruction manual. The final positive clones were sequenced and their sequences were compared with the Genbank nucleotide database.

Bioinformatics Analysis

The p49/STRAP and NDUFAB1 sequences were subjected to analyses using web-based and/or freely-downloaded bioinformatic tools, including "PSORT II" [4], "iPSORT" [5], "WoLF PSORT", "BaCelLo" [6], "pTARGET" [7], "CELLO version 2" [8], "Golgi Localization Predictor" [9], "HSLPred" [10], "GoCore" and "SignalP" [11].

Cloning of Full-length Coding Region Sequence of NDUFAB1 gene

The majority of the cDNA clones interacting with the N-terminal bait of the p49/STRAP protein in the yeast two-hybrid screening matched a single gene in the GenBank database, NDUFAB1, which is a subunit of NADH dehydrogenase (OMIM 25010; EC 1.6.5.3). The full-length coding region of the human NDUFAB1 gene was amplified by PCR using a human heart cDNA sample (Clontech) and then subcloned into the expression vectors.

Plasmid Constructs

A pcDNA3-Flag-NDUFAB1 construct was generated by ligating the NDUFAB1 coding region in frame with Flag into the pcDNA3-Flag vector. A pcDNA3-mCherry-NDUFAB1 construct was generated by ligating the mCherry red fluorescent protein (RFP, a gift from Dr. Roger Tsien, University of California, San Diego) in frame with NDUFAB1 into the pcDNA3 vector. The p49/STRAP-EGFP fusion protein construct and the pcDNA3-HA-p49/STRAP construct were generated as previously reported [1]. All the plasmid constructs were subjected to sequencing analysis to verify the open reading frame sequence.

Generation of Recombinant Adenoviruses

The p49/STRAP recombinant adenovirus was generated using the AdEasy system, a generous gift from Dr. Vogelstein (The Johns Hopkins Oncology Center, Baltimore) [12]. The generation, purification and titration of the recombinant adenoviruses Ad-EGFP and Ad-p49/STRAP were performed according to the protocol described by He et al. [12].

Tissue Culture and Transfection Assays

The H9C2 cells, NIH3T3 cells and neonatal rat cardiac myocytes were cultured as previously described [1, 13, 14]. Transient transfection was carried out using the desired expression plasmid constructs and the Lipofectamine 2000 reagent (Invitrogen). At approximately 4 hr after the transfection was initiated, cells were placed in DMEM medium containing 10% newborn bovine serum and incubated at 37°C overnight.

Co-immunoprecipitation and Western Blotting

The expression plasmid constructs containing p49/STRAP and NDUFAB1 were cotransfected into NIH3T3 cells by using Lipofectamine 2000 (Invitrogen) as previously described [1]. At 48 h after the transfection, cells were harvested, and the whole-cell lysate was isolated. The co-immunoprecipitation and Western blotting were carried out as previously described [1]. Antibodies that were employed included monoclonal antibodies HA.11 (Covance), FLAG (M2, Sigma), SRF (Abcam) and an anti-acetyl-Lysine antibody (clone 4G12, Upsate); polyclonal antibodies HA (Santa Cruz), Flag (Sigma), a SRF antibody which recognizes the C-terminus of SRF protein (Santa Cruz) and p49/Strap [1].

Fluorescence Microscopy

The expression plasmids "EGFP-p49/STRAP" and "mCherry-NDUFAB1" were used for the transfection. At approximately 24, 48, and 72 hours after transfection, the expression of EGFP-p49/STRAP and mCherry-NDUFAB1 were examined by fluorescence microscopy using a Nikon Eclipse E600 equipped with CoolSNAP-ES digital camera and MetaVue 6.2 software.

The intensity of fluorescence was measured using the "ImageJ 1.37" program (National Institutes of Health, Bethesda, MD). Background noise was subtracted. The area of, and total fluorescence signal from, nuclear and non-nuclear cellular regions were measured separately. The cytoplasm superior and inferior to the nucleus was estimated to have a p49/STRAP concentration similar to that in the perinuclear region. It was further estimated that the cytoplasmic overlay on the nucleus was thinner than that of the surrounding region. For these reasons, the total fluorescence in the nuclear region was estimated to consist of p49 in the nucleus proper, and an amount of p49 represented by the product of the intensity of signal in the extranuclear region and the area of the nucleus itself.

Nuclear p49 signal = Total Nuclear Signal - (Extranuclear Signal Intensity × Nuclear Area)

In addition, the cytosolic fraction of p49 was estimated to be a ratio of cytosolic signal to the total signal.
Cytosolic p49 (%) = 100  ×  Cytosolic Signal ( Cytosolic  +  Nuclear )  Signal MathType@MTEF@5@5@+=feaagaart1ev2aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacPC6xNi=xI8qiVKYPFjYdHaVhbbf9v8qqaqFr0xc9vqFj0dXdbba91qpepeI8k8fiI+fsY=rqGqVepae9pg0db9vqaiVgFr0xfr=xfr=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@7ECF@

NAD/NADH Assay

The H9C2 cells were used for the assessment of NAD/NADH ratio in response to p49/STRAP gene expression. The NAD assay was performed using a protocol modified from the methods described by Zerez et al. [15] as well as Bernofsky and Swan [16], in which H9C2 cells were infected with 25 MOI of recombinant adenoviruses 48 hours before the assay was performed. The values are expressed as means ± S.D. A p value of less than 0.05 was considered to be significant.

Results

NDUFAB1 is a p49/STRAP binding protein

p49/STRAP was first identified as a transcription cofactor of SRF [1]. To explore a broad spectrum of potential p49/STRAP binding proteins, we employed a yeast two-hybrid system in which two overlapping cDNA fragments covering the entire p49 protein were used as baits to screen two human cDNA libraries. The utilization of separate bait fragments, p49/STRAP N-terminus (p49-N) and p49/STRAP C-terminus (p49-C), was intended to maximize the screening efficiency and to distinguish the binding proteins that may selectively interact with the different parts of the p49 protein.

A human heart cDNA library derived from terminally differentiated cardiomyocytes and non-cardiomyocyte cells, and a Hela cell cDNA library generated from highly proliferating tumor cells were selected to represent the cells with different biological features.

When the human heart cDNA library was screened with p49-N bait, 42 out of 44 (95%) of the final target clones that were analyzed matched a single gene, NDUFAB1, which is a subunit of NADH dehydrogenase I. When the Hela cell cDNA library was screened, 8 out of 20 (40%) clones matched NDUFAB1 (table 1). Since NDUFAB1 cDNA clones were the main p49/STRAP interacting protein in two screenings with p49-N bait, we wondered whether NDUFAB1 could also be a major target for the p49-C bait screening.
Table 1

The NDUFAB1 protein selectively binds to the N-terminus of p49 protein (p49-N).

Origin of cDNA Library

Screening bait

Clones positive for NDUFAB1

Main target

Haert

p49-N

95%

NDUFAB1

Hela

p49-N

40%

NDUFAB1

Hela

p49-C

0%

Other

Three separate yeast two-hybrid screenings were performed using p49-N and p49-C as bait, respectively. When p49-N was used to screen human heart cDNA library, 42 out of 44 (95%) of the positive clones that interacted with p49-N were NDUFAB1. When p49-N was used to screen Hela cell cDNA library, 8 out of 20 (40%) of the positive clones were NDUFAB1. However, when p49-C was used to screen Hela cell cDNA library, none of the clones was NDUFAB1. These results indicate that p49-N selectively binds to NDUFAB1.

In a third screening, the p49-C bait plasmid was used to screen the Hela cell library and 41 final target clones were analyzed. However, no clone matched to NDUFAB1 (0%) (table 1). These data indicate that NDUFAB1 protein selectively binds the N-terminus of p49/STRAP (figure 1a).
Figure 1
Figure 1

NDUFAB1 binds to p49/STRAP. A. Schematic representation indicating that NDUFAB1 binds to the N-terminus of p49/STRAP protein. B. H9C2 cells were transfected with Flag-NDUFAB1 plasmid construct and harvested 24 hours later. An anti-IgG antibody (used as a control) and an anti-p49 antibody were used in the co-immunoprecipitation assay. The results show that p49 antibody co-immunoprecipitated the endogenous p49 protein and the Flag-NDUFAB1 protein, indicating that Flag-NDUFAB1 was bound to endogenous p49 protein. C. Flag-NDUFAB1 expression did not change p49 protein level in the cells (figure 1c).

To confirm the interaction between p49/STRAP and NDUFAB1 in the mammalian cells, we performed immunoprecipitation assays. As shown in figure 1b, immunoprecipitation of the endogenous p49/STRAP protein with anti-p49 antibody co-precipitated the NDUFAB1 protein. The expression of NDUFAB1 plasmid construct did not change the level of p49/STRAP protein in the cells (figure 1c).

Bioinformatics analysis of p49/STRAPand NDUFAB1

To determine the functional and conserved domains in p49/STRAP and NDUFAB1, we used web-based bioinformatic tools to analyze the protein sequences of these two genes.

Analysis of p49/STRAP showed that it contains as many as four classic NLS motifs (figure 2). Two bipartite NLS motifs were located at the N-terminus of the sequence, including NLS #1 at codons 17–33, and NLS #2 at codons 41–57. NLS #3 is a classic pattern-7 (pat7) NLS motif with seven amino acid residues (PLLKKKI) at 107–113, and NLS #4 is a classic pattern-4 NLS motif with four residues (RRRK) at 408–411. Overall, the intracellular localization of p49/STRAP was predicted to be 65.2% nuclear, 21.7% cytoplasmic, 4.3% mitochondrial, 4.3% in vesicles of secretory system and 4.3% in endoplasmic reticulum (table 2).
Figure 2
Figure 2

Bioinformatics analysis of p49 sequence. Bioinformatics analysis of the sequence of human p49 protein shows that there are four classic nuclear localizing sequences (NLS's), three of them are in the N-terminal region. NLS1 & NLS2 are bipartite nuclear localization sequences. NLS3 has a pattern-7 motif, and NLS4 has a pattern-4 motif. Blue (residue K or R) indicates positively charged (basic) residues, red (residue D or E) indicates negatively charged (acidic) residues. The sections underlined in green are highly conserved across human, rat, and mouse.

Table 2

Bioinformatics estimate of intracellular localization probability of p49 and NDUFAB1.

Intracellular site

p49/STRAP

NDUFAB1

Nucleus

65.2%

8.7%

Cytoplasm

21.7%

8.7%

Vesicles of secretory

4.3%

0.0%

Mitochondria

4.3%

78.3%

Endoplasmic reticulum

4.3%

0.0%

Cytoskeleton

0.0%

4.3%

Multiple bioinformatics programs were used to analyze the potential intracellular localization of the p49 and NDUFAB1 proteins (see details in "Methods"). The results estimate that p49 protein is primarily localized within the nucleus, and NDUFAB1 is primarily localized in the mitochondria, although both proteins have the potential to be in other intracellular compartments as well.

Analysis of NDUFAB1 revealed that NDUFAB1 was estimated to be 78.3% mitochondrial, 8.7% nuclear, 8.7% cytoplasmic and 4.3% cytoskeletal (table 2).

Intracellular localization of NDUFAB1

NDUFAB1, which is a nuclear-encoded protein, is a subunit of the mitochondrial respiratory Complex I. To visualize the localization of NDUFAB1 in living cells, a red fluorescent protein (RFP), mCherry, was linked in-frame with NDUFAB1 and expressed in the H9C2 cells. As shown in figure 3a, the RFP-NDUFAB1 was observed to be present in both the cytoplasm and nucleus.
Figure 3
Figure 3

Intracellular localization of p49 and NDUFAB1. Fluorescent images of H9C2 cells transfected with NDUFAB1-RFP expression plasmids (a, top left) and RFP control (b, top right), demonstrate both nuclear and cytoplasmic distribution. The p49-GFP fusion protein appears to be primarily localized within the nucleus, especially the nucleoli (c, bottom left). The GFP-only control protein is distributed evenly throughout the cells (d, bottom right). GFP = green fluorescent protein; RFP red fluorescent protein.

Intracellular localization of p49/STRAP

The EGFP-p49/STRAP expression plasmid was transfected into H9C2 cells, neonatal cardiac myocytes and NIH3T3 cells. In the un-stimulated H9C2 cells, EGFP-p49/STRAP fusion protein was observed predominantly within the nucleus (figures 3c &4a). Nevertheless, in a small subset of the H9C2 cells, p49/STRAP was also observed in both nucleus and cytoplasm. Similar results were also observed in neonatal cardiac myocytes and NIH3T3 cells (data not shown).
Figure 4
Figure 4

Intracellular localization of p49 protein in cultured H9C2 cells. Image analyses was performed on more than 200 H9C2 cells transfected with p49-GFP at 1,2 and 3 days after transfection. Cytosolic and nuclear signal intensity of p49 was computed using "Image J" program (see description in "Methods"). Top Panel: No significant relationship was found between p49-GFP cytosolic fraction and day post-transfection(Day, x axis). Bottom Panel: Images of cells with p49-GFP evident in the extranuclear region were measured after subtracting the background noise. The images were grouped based on the number of days post-transfection. In our studies, cell growth displayed a negative quadratic function during days 1–3 post-transfection (R2adj = 0.273, regression not shown).

To determine whether the incubation time after transfection could affect the localization of the p49 protein, cells were also observed at three time points (24 hours, 48 hours and 72 hours) after transfection. At all three time points, p49 localized predominantly in the nucleus in the majority of the cells, with no appreciable relationship with the time post-transfection (figures 4 and 5). However, the cytosolic localization of total p49/STRAP did seem to be slightly related to the degree of confluency (figure 5).
Figure 5
Figure 5

Statistical indication that only a minority of the p49 protein is observed in the cytoplasm. Based on our analyses (see detail in the "Methods" section), approximately less than 30% of the protein is located in the cytoplasm. Cells were counted using brightfield microscopy and the images were grouped by days post-transfection as shown in figure 4. It is interesting to note that both the absolute value of, and variability in, the cytosolic percent seem to be reduced with increased confluence in cell count. The absolute residuals were regressed against the cell count, and the resulting function added (+/-) to the function of the original regression, resulting in the "band" shown in gray. Taken together, the simple least squares regression and residual regression on cell count account for >43% of the variability in cytosolic percent. This implies that p49 is localized predominantly in the nucleus. The result is independent of day of culture, and only slightly influenced by degree of cell confluence.

When H9C2 cells were transfected with both p49/STRAP and NDUFAB1 expression plasmids, co-localization of the p49/STRAP and NDUFAB1 proteins was observed (figure 6).
Figure 6
Figure 6

Co-expression of p49 and NDUFAB1. Fluorescent images of H9C2 cells showing uneven distribution p49-EGFP fusion protein alone, in green (a) and NDUFAB1-RFP fusion protein alone, in red (b). Co-expression of p49 and NDUFAB1 fusion proteins indicates co-localization of these two proteins that appear as yellow in the nuclear region (c). These panels, taken together with those of figs. 3a-3d, suggest a more focal localization of p49-GFP compared to control (a, c) in these cells. However, for the NDUFAB1-RFP construct (b, c), the distribution usually appears to be more even throughout the cell, similar to that of GFP-only and RFP-only controls (d, e, f). GFP = green fluorescent protein; RFP = red fluorescent protein.

p49/STRAP expression affected NAD/NADH ratio

NDUFAB1 is a subunit of NADH dehydrogenase that regulates intracellular NAD, NADH concentrations and the NAD/NADH ratio. To determine whether the interaction between p49/STRAP and NDUFAB1 would have any effect on NADH dehydrogenase activity, thereby affecting the NAD/NADH ratio, p49/STRAP was delivered into cells with recombinant adenovirus, and the cycling assay for NAD/NADH was then performed [15, 16]. The results revealed that NAD concentration was 258 ± 12.4 nM in control adenovirus treated cells, but 165 ± 15.0 nM in p49/STRAP adenovirus treated cells; NADH concentration was 1065 + 15.5 nM in control adenovirus treated cells, but 1105 ± 24.6 nM in p49/STRAP adenovirus treated cells. The NAD/NADH ratio was 0.24 ± 0.016 in control adenovirus treated cells, while 0.14 ± 0.012 in p49/STRAP adenovirus treated cells. The results indicate that p49/STRAP adenovirus reduced the intracellular NAD/NADH ratio by approximately 40% (p < 0.05, n = 4) (figure 7).
Figure 7
Figure 7

Overexpression of p49/STRAP changes the intracellular NAD/NADH ratio. H9C2 cells were infected with either recombinant adenovirus containing empty vector (control) or p49/STRAP gene (Ad-p49), respectively. After 48 hours, the cells were harvested and the cell lysate samples were subjected to NAD and NADH assay(see methods). The results indicate that p49/STRAP overexpression reduces the intracellular NAD/NADH ratio by approximately 40% in H9C2 cells (p < 0.05, n = 4).

Overexpression of p49/STRAP also reduced the acetylation of SRF (figure 8). These data implicate p49 as an inducer of SRF deacetylation.
Figure 8
Figure 8

p49/STRAP reduces the level of acetylated-SRF protein. H9C2 cells were transfected with p49 plasmid construct (p49-plasmid) or with empty vector (empty vector) and harvested after 24 hours. H9C2 cells without transfection (No treatment) were used as controls. Equal amounts of the protein from the above samples were used to immunoprecipitate the SRF protein, using an antibody recognizing the C-terminal SRF protein (Santa Cruz). The immunoprecipitated SRF proteins were then subjected to SDS-PAGE and Western blotting. The level of total SRF protein in the samples was determined using the same anti-SRF antibody. The acetylated-SRF was detected by an antibody specifically recognizing the acetyl-lysine (clone 4G12, Upstate biotechnology). The results indicate that p49/STRAP overexpression reduces the level of acetylated-SRF protein.

Discussion

The p49/STRAP protein was initially isolated by our group as a transcription cofactor of SRF, which modulates the transcriptional regulation of SRF-target genes [1]. In the present study, we found that p49/STRAP contained four classic NLS motifs. The p49 protein predominantly localized within the nucleus, but was also present at low levels in the cytoplasm. In addition, we found that p49/STRAP interacted with NDUFAB1, a subunit of the mitochondrial Complex I which regulates the redox status of NAD/NADH, and showed that NDUFAB1 could be observed in both the cytoplasm and nucleus. Furthermore, we found that overexpression of p49/STRAP altered the intracellular level of NAD and NADH, and reduced the NAD/NADH ratio. Overexpression of p49/STRAP also resulted in reduction of the acetylation of SRF. These results suggest that via interacting with a component of Complex I, p49/STRAP plays a role in the regulation of NAD and NADH which influence fundamental cellular processes such as cellular metabolism, gene expression, ion channel regulation and possibly aging [17–19].

It is known that Complex I, an enzyme complex that is located on the inner mitochondrial membrane catalyzes the transfer of electrons from NADH to coenzyme Q (CoQ). In the redox process, the complex translocates electrons across the inner membrane, helping to build the electrochemical potential used to produce ATP [20]. However, the exact catalytic mechanism remains incompletely established. Complex I is the largest respiratory complex, which contains 46 separate subunits. Of the 46 subunits, seven are encoded by the mitochondrial genome, while the rest are encoded by the nuclear genome.

NDUFAB1 is one of the nuclear-encoded subunits of Complex I, which contains a phosphopantetheine attachment site (DLGLDSLDQVEIIMAM), Characteristic of acyl carrier proteins. NDUFAB1 also contains an EF-hand calcium binding domain (DIDAEKLMCPQEI) [21]. Deletion of NDUFAB1 homolog in N. crassa results in impaired assembly of Complex I and a four-fold increase in lysophospholipid content of mitochondrial membranes, suggesting that NDUFAB1 is required for the assembly of Complex I, and that it is also involved in fatty acid synthesis [22]. Although NDUFAB1 was considered to be a membrane bound component of Complex I, recent evidence indicates that soluble NDUFAB1 protein has been found in the mitochondria, suggesting that NDUFAB1 may have other functions [23].

In the present study, NDUFAB1 was identified as a major binding protein to the p49/STRAP-N region. NDUFAB1 accounted for 95% of the cDNA clones derived from human heart and 40% of the cDNA clones derived from human Hela cells, which interacted with the p49-N region. NDUFAB1 mRNA is expressed in a wide range of human tissues. The highest expression levels are observed in adult heart, skeletal muscle and fetal heart [21]. Although majority of the cDNA clones derived from human heart and Hela cells interacted with the p49-N region, none of the clones interacted with the p49-C region. These data suggest that the high binding rate of NDUFAB1 to p49/STRAP N-terminus is unlikely to be random, and is unlikely to be associated merely with the expression level of NDUFAB1 in the tissue origin of the cDNA library. Rather, this suggests that the NDUFAB1 protein binds selectively to the N-terminus, but not the C-terminus, of the p49/STRAP protein.

The translocation of a protein from the cytoplasm through the nuclear pore complex and into the nucleoplasm is usually initiated through the interaction between an NLS motif on the cargo protein with the NLS motif binding site on importin-α [24]. The classic nuclear localization sequence generally conform to one of three types, known as pattern-4 (pat4), pattern-7 (pat7) (both are monopartite) and bipartite motifs [25–27]. The "pat4" NLS motif consists of a continuous stretch of four basic amino acids (lysine or arginine) or three basic amino acids associated with histidine or proline. The "pat7" NLS motif starts with a proline and is followed within three residues by an amino acid sequence containing three basic residues out of four. The third type of NLS motif, known as "bipartite" motif, consists of two basic amino acids, a 10 amino acid spacer and a five amino acid sequence containing at least three basic residues [25–27]. All four NLS motifs of the p49/STRAP protein comply with the classic definitions of NLS motifs. Our bioinformatic analyses also suggest that p49/STRAP could potentially localize in the other cellular compartments; likewise, NDUFAB1 may also be in the nucleus.

It is well documented that a single gene can give rise to more than one protein products with different sizes and with the potential to be localized to different intercellular compartments. These proteins can be derived from alternative splicing, or differential usage of translational initiation signals, thereby containing or lacking specific compartment targeting signals.

Recent studies indicate that even a single protein product can have the potential for dual intracellular localization. For example, wild-type p53 has been observed in cytoplasm and nucleus in both normal and tumor cells [28]. p53 protein is accumulated in mitochondria and nuclei of cardiac myocytes after treatment with Adriamycin [29]. Chronological observation of p53 protein revealed that upon TPA treatment, p53 was first translocated into mitochondria, and then into nucleus [30]. Other examples of protein with dual localization include BCL2, SRF, ERK, Myopodin, 14-3-3 proteins, MKP-1 protein, thioredoxin and BRCA1 [31–38].

It is considered that the localization signal sequence(s) in proteins play a major role in compartment localization of the proteins. Proteins that harbor two separate signals or an overlapping ambiguous signal, and even only one signal sequence may follow dual distribution in the cell [39]. The mechanism of dual targeting is driven by the competition of various molecular events. Protein folding, post-translational modification and protein-protein interaction are key players in this phenomenon [39]. Since proteins are generally considered to be translated in the cytosol, cytosol may be considered the default compartment for soluble proteins that do not transit to their initial programmed destination. The p49-N region contains three NLS motifs. Our data revealed that NDUFAB1 selectively interacted with p49-N region. It is possible that interaction of p49 with NDUFAB1 and other p49-binding protein(s) could make the NLS motifs of p49 protein unaccessible, thereby leading to the retention of p49 in the cytoplasm, as evidenced by the presence of p49 protein at low levels in the cytoplasm. Likewise, similar mechanisms could lead to the retention of NDUFAB1 in cytoplasm. It is also possible that the interaction between p49 and NDUFAB1 could retain both proteins within the cytoplasm, thus affecting their arrival at their programmed destination.

A recent study by Lisinski et al. reported that p49/STRAP is a cytosolic protein and was mainly localized to the cytoplasm [40]. Apparently Lisinski and colleagues performed microscopic analysis on the cells three days after transfection assay. In the current study, the cells were analyzed at 24 hours, 48 hours and 72 hours after the transfection was initiated. p49/STRAP protein was observed in the nucleus in all of cells in which transfection was successful. However, p49 was present in both nucleus and cytoplasm in a minority of the cells. In addition, the fraction of total p49 protein accounted for by the cytosolic portion seemed to decrease, both in absolute value and variability, with the degree of confluency. Therefore, the differences between the two groups could be partly due to different culture conditions. It is also possible that the p49/STRAP protein could have differing localization under different conditions. Protein modifications including phosphorylation may also influence nuclear transport of p49/STRAP.

Inasmuch as p49/STRAP interacted with NDUFAB1 and had an impact on the intracellular NAD/NADH ratio, it is possible that the interaction affects the assembly of Complex I. Recently, it was reported that the transcription factor TFII-I plays a role outside the nucleus as an inhibitor of the cell surface Ca2+ channel TRPC3 by competing for binding to phospholipase C-g (PLC-g) [41]. Similarly, p49/STRAP may also play a role outside of the nucleus. It is also possible that binding of NDUFAB1 by p49/STRAP could alter the ability of NDUFAB1 to enter mitochondria and/or could affect the assembling of Complex I, thereby altering its function and possibly the NAD/NADH ratio.

In this study, it was found that overexpression of p49/STRAP reduced the level of acetylated-SRF protein, suggesting that p49/STRAP may play a role in the regulation of SRF through the process of acetylation and deacetylation. Recent studies reveal that reversible acetylation of non-histone proteins, including transcription factors, play an important role in the regulation of gene expression. The reversible acetylation of non-histone proteins is usually carried out by histone acetyltransferases (HATs) and histone deacetylases (HDACs). The HATs and HDACs are often found to be binding proteins of a number of transcription factors and cofactors, and have also been found to be in protein complexes containing certain transcription factors and cofactors [42, 43]. In addition, certain transcription cofactors have been proven to be new members of a growing family of acetyltransferases and deacetylases)[42–45]. It will be interesting to know the mechanisms by which p49/STRAP induces the deacetylation of the SRF protein. It is possible that p49/STRAP may function as a deacetylase that deacetylates SRF directly. It is also possible that p49/TRAP change the intracellular NAD/NADH ratio thereby activating (or recruiting) certain deacetylase(s) which in turn reduce the level of acetylated-SRF protein.

Conclusion

The findings in the present study demonstrate that p49/STRAP regulates intracellular NADH/NAD ratio and SRF deacetylation. The mechanism of regulation of NADH/NAD ratio by p49/STRAP is incompletely established at this time and remains to be further investigated. We plan to study the mechanism(s) in the future.

Abbreviations

NADH: 

Nicotinamide adenine dinucleotide hydride

NAD: 

Nicotinamide adenine dinucleotide

p49/STRAP: 

"SRF-dependent transcription regulation-associated protein" which is a 49-kilodalton protein

SRFBP1: 

"serum response factor binding protein 1" which is a synonym of p49/STRAP

NDUFAB1: 

NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1, 8 kDa

HA: 

Hemagglutinin

SRF: 

Serum response factor

Zipzap/p200: 

"Zinc finger protein with activation potential" which is 200-kilodalton protein

EGFP: 

Enhanced green fluorescent protein

MOI: 

Multiplicity of infection

NLS: 

Nuclear localization sequence

pat4: 

Pattern-4

pat7: 

Pattern-7.

Declarations

Acknowledgements

We are grateful to Dr. R. Tsien for m-Cherry red fluorescent protein, Dr. Vogelstein for AdEasy system. Supported in part by NIH grant #AG026091, The Central Arkansas Veterans Healthcare system, and the University of Arkansas for Medical Sciences.

Authors’ Affiliations

(1)
From the Donald W. Reynolds Department of Geriatrics, The University of Arkansas for Medical Sciences and Geriatric Research, Education, and Clinical Center, Little Rock, AR, USA
(2)
Central Arkansas Veterans Healthcare System, Geriatric and Extended Care, Little Rock, AR, USA
(3)
Central Arkansas Veterans Healthcare System, Little Rock, AR, USA

References

  1. Zhang X, Azhar G, Zhong Y, Wei JY: Identification of a novel serum response factor cofactor in cardiac gene regulation. J Biol Chem. 2004, 279 (53): 55626-55632. 10.1074/jbc.M405945200.View ArticlePubMedGoogle Scholar
  2. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, Brown T, Yang J, Khrapko K, Borras AM, Lawitts J: Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol. 2001, 280 (4): H1782-1792.PubMedGoogle Scholar
  3. Zhang X, Azhar G, Zhong Y, Wei JY: Zipzap/p200 is a novel zinc finger protein contributing to cardiac gene regulation. Biochem Biophys Res Commun. 2006, 346 (3): 794-801. 10.1016/j.bbrc.2006.05.211.View ArticlePubMedGoogle Scholar
  4. Nakai K, Horton P: PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci. 1999, 24 (1): 34-36. 10.1016/S0968-0004(98)01336-X.View ArticlePubMedGoogle Scholar
  5. Bannai H, Tamada Y, Maruyama O, Nakai K, Miyano S: Extensive feature detection of N-terminal protein sorting signals. Bioinformatics. 2002, 18 (2): 298-305. 10.1093/bioinformatics/18.2.298.View ArticlePubMedGoogle Scholar
  6. Pierleoni A, Martelli PL, Fariselli P, Casadio R: BaCelLo: a balanced subcellular localization predictor. Bioinformatics. 2006, 22 (14): e408-416. 10.1093/bioinformatics/btl222.View ArticlePubMedGoogle Scholar
  7. Guda C, Subramaniam S: pTARGET [corrected] a new method for predicting protein subcellular localization in eukaryotes. Bioinformatics. 2005, 21 (21): 3963-3969. 10.1093/bioinformatics/bti650.View ArticlePubMedGoogle Scholar
  8. Yu CS, Chen YC, Lu CH, Hwang JK: Prediction of protein subcellular localization. Proteins. 2006, 64 (3): 643-651. 10.1002/prot.21018.View ArticlePubMedGoogle Scholar
  9. Yuan Z, Teasdale RD: Prediction of Golgi Type II membrane proteins based on their transmembrane domains. Bioinformatics. 2002, 18 (8): 1109-1115. 10.1093/bioinformatics/18.8.1109.View ArticlePubMedGoogle Scholar
  10. Garg A, Bhasin M, Raghava GP: Support vector machine-based method for subcellular localization of human proteins using amino acid compositions, their order, and similarity search. J Biol Chem. 2005, 280 (15): 14427-14432. 10.1074/jbc.M411789200.View ArticlePubMedGoogle Scholar
  11. Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol. 2004, 340 (4): 783-795. 10.1016/j.jmb.2004.05.028.View ArticlePubMedGoogle Scholar
  12. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998, 95 (5): 2509-2514. 10.1073/pnas.95.5.2509.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Turner NA, Xia F, Azhar G, Zhang X, Liu L, Wei JY: Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells. J Mol Cell Cardiol. 1998, 30 (9): 1789-1801. 10.1006/jmcc.1998.0743.View ArticlePubMedGoogle Scholar
  14. Zhang X, Azhar G, Nagano K, Wei JY: Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J Am Coll Cardiol. 2001, 38 (7): 2055-2062. 10.1016/S0735-1097(01)01665-5.View ArticlePubMedGoogle Scholar
  15. Zerez CR, Lee SJ, Tanaka KR: Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal Biochem. 1987, 164 (2): 367-373. 10.1016/0003-2697(87)90506-9.View ArticlePubMedGoogle Scholar
  16. Bernofsky C, Swan M: An improved cycling assay for nicotinamide adenine dinucleotide. Anal Biochem. 1973, 53 (2): 452-458. 10.1016/0003-2697(73)90094-8.View ArticlePubMedGoogle Scholar
  17. Zhang Q, Piston DW, Goodman RH: Regulation of corepressor function by nuclear NADH. Science. 2002, 295 (5561): 1895-1897.PubMedGoogle Scholar
  18. Meissner G: NADH, a new player in the cardiac ryanodine receptor?. Circ Res. 2004, 94 (4): 418-419. 10.1161/01.RES.0000122072.43826.98.View ArticlePubMedGoogle Scholar
  19. Lin SJ, Guarente L: Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol. 2003, 15 (2): 241-246. 10.1016/S0955-0674(03)00006-1.View ArticlePubMedGoogle Scholar
  20. Brandt U: Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem. 2006, 75: 69-92. 10.1146/annurev.biochem.75.103004.142539.View ArticlePubMedGoogle Scholar
  21. Triepels R, Smeitink J, Loeffen J, Smeets R, Buskens C, Trijbels F, van den Heuvel L: The human nuclear-encoded acyl carrier subunit (NDUFAB1) of the mitochondrial complex I in human pathology. J Inherit Metab Dis. 1999, 22 (2): 163-173. 10.1023/A:1005402020569.View ArticlePubMedGoogle Scholar
  22. Schneider R, Massow M, Lisowsky T, Weiss H: Different respiratory-defective phenotypes of Neurospora crassa and Saccharomyces cerevisiae after inactivation of the gene encoding the mitochondrial acyl carrier protein. Curr Genet. 1995, 29 (1): 10-17. 10.1007/BF00313188.View ArticlePubMedGoogle Scholar
  23. Cronan JE, Fearnley IM, Walker JE: Mammalian mitochondria contain a soluble acyl carrier protein. FEBS Lett. 2005, 579 (21): 4892-4896. 10.1016/j.febslet.2005.07.077.View ArticlePubMedGoogle Scholar
  24. Gorlich D, Kutay U: Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol. 1999, 15: 607-660. 10.1146/annurev.cellbio.15.1.607.View ArticlePubMedGoogle Scholar
  25. Kalderon D, Roberts BL, Richardson WD, Smith AE: A short amino acid sequence able to specify nuclear location. Cell. 1984, 39 (3 Pt 2): 499-509. 10.1016/0092-8674(84)90457-4.View ArticlePubMedGoogle Scholar
  26. Robbins J, Dilworth SM, Laskey RA, Dingwall C: Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell. 1991, 64 (3): 615-623. 10.1016/0092-8674(91)90245-T.View ArticlePubMedGoogle Scholar
  27. Hicks GR, Raikhel NV: Protein import into the nucleus: an integrated view. Annu Rev Cell Dev Biol. 1995, 11: 155-188. 10.1146/annurev.cb.11.110195.001103.View ArticlePubMedGoogle Scholar
  28. Sembritzki O, Hagel C, Lamszus K, Deppert W, Bohn W: Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein. Neuro Oncol. 2002, 4 (3): 171-178. 10.1215/15228517-4-3-171.PubMed CentralPubMedGoogle Scholar
  29. Nithipongvanitch R, Ittarat W, Cole MP, Tangpong J, Clair DK, Oberley TD: Mitochondrial and Nuclear p53 Localization in Cardiomyocytes: Redox Modulation by Doxorubicin (Adriamycin)?. Antioxid Redox Signal. 2007, 9 (7): 1001-1008. 10.1089/ars.2007.1632.View ArticlePubMedGoogle Scholar
  30. Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, St Clair DK: p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005, 65 (9): 3745-3750. 10.1158/0008-5472.CAN-04-3835.View ArticlePubMedGoogle Scholar
  31. Hoetelmans R, van Slooten HJ, Keijzer R, Erkeland S, van de Velde CJ, Dierendonck JH: Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells. Cell Death Differ. 2000, 7 (4): 384-392. 10.1038/sj.cdd.4400664.View ArticlePubMedGoogle Scholar
  32. Lu XG, Azhar G, Liu L, Tsou H, Wei JY: SRF binding to SRE in the rat heart: influence of age. J Gerontol A Biol Sci Med Sci. 1998, 53 (1): B3-10.View ArticlePubMedGoogle Scholar
  33. Reffas S, Schlegel W: Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells. Biochem J. 2000, 352 (Pt 3): 701-708. 10.1042/0264-6021:3520701.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C, Mundel P: Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome. Oncogene. 2003, 22 (34): 5298-5305. 10.1038/sj.onc.1206616.View ArticlePubMedGoogle Scholar
  35. Faul C, Huttelmaier S, Oh J, Hachet V, Singer RH, Mundel P: Promotion of importin alpha-mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3. J Cell Biol. 2005, 169 (3): 415-424. 10.1083/jcb.200411169.PubMed CentralView ArticlePubMedGoogle Scholar
  36. Hutter D, Chen P, Barnes J, Liu Y: Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem J. 2000, 352 (Pt 1): 155-163. 10.1042/0264-6021:3520155.PubMed CentralView ArticlePubMedGoogle Scholar
  37. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, Yodoi J: Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem. 1999, 274 (39): 27891-27897. 10.1074/jbc.274.39.27891.View ArticlePubMedGoogle Scholar
  38. Thompson ME, Robinson-Benion CL, Holt JT: An amino-terminal motif functions as a second nuclear export sequence in BRCA1. J Biol Chem. 2005, 280 (23): 21854-21857. 10.1074/jbc.M502676200.View ArticlePubMedGoogle Scholar
  39. Karniely S, Pines O: Single translation – dual destination: mechanisms of dual protein targeting in eukaryotes. EMBO Rep. 2005, 6 (5): 420-425. 10.1038/sj.embor.7400394.PubMed CentralView ArticlePubMedGoogle Scholar
  40. Lisinski I, Matsumoto H, Yver DR, Schurmann A, Cushman SW, Al-Hasani H: Identification and characterization of p49/STRAP as a novel GLUT4-binding protein. Biochem Biophys Res Commun. 2006, 344 (4): 1179-1185. 10.1016/j.bbrc.2006.04.017.View ArticlePubMedGoogle Scholar
  41. Caraveo G, van Rossum DB, Patterson RL, Snyder SH, Desiderio S: Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry. Science. 2006, 314 (5796): 122-125. 10.1126/science.1127815.View ArticlePubMedGoogle Scholar
  42. Freiman RN, Tjian R: Regulating the regulators: lysine modifications make their mark. Cell. 2003, 112 (1): 11-17. 10.1016/S0092-8674(02)01278-3.View ArticlePubMedGoogle Scholar
  43. Johnstone RW: Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov. 2002, 1 (4): 287-299. 10.1038/nrd772.View ArticlePubMedGoogle Scholar
  44. Naar AM, Lemon BD, Tjian R: Transcriptional coactivator complexes. Annu Rev Biochem. 2001, 70: 475-501. 10.1146/annurev.biochem.70.1.475.View ArticlePubMedGoogle Scholar
  45. Yang XJ: Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays. 2004, 26 (10): 1076-1087. 10.1002/bies.20104.View ArticlePubMedGoogle Scholar

Copyright

© Zhang et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

BMC Molecular and Cell Biology

ISSN: 2661-8850

Contact us